| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LEW
|
8,750.00 | 4.5B | 1.32 | 0.82 | 1.08 | 13.6% | 15.9% | 75 | 41 | 16,206.20 | +61.3% | 69 | 0.43 |
|
CMH
|
3,872.00 | 2.7B | 1.72 | 1.83 | 0.99 | 21.6% | 14.7% | 72 | 47 | 5,862.37 | +37.0% | 72 | 1.45 |
|
ITE
|
873.00 | 10.2B | 1.90 | 1.36 | 1.03 | 20.4% | 17.6% | 72 | 38 | 1,297.11 | +35.0% | 86 | 0.13 |
|
TRU
|
4,522.00 | 16.4B | 1.46 | 1.52 | 1.55 | 13.0% | 15.8% | 72 | 37 | 6,892.91 | +37.7% | 68 | 0.52 |
|
CSB
|
10,864.00 | 2.2B | 2.67 | 1.20 | 0.84 | 20.2% | 14.9% | 71 | 44 | 15,103.15 | +28.1% | 78 | 0.88 |
|
ACT
|
72.00 | 589.4M | — | 0.31 | 0.08 | 7.8% | 14.2% | 68 | 60 | 190.13 | +121.4% | 81 | 0.39 |
|
PPH
|
1,928.00 | 71.0B | 2.95 | 1.09 | 1.84 | 8.8% | 14.4% | 64 | 32 | 2,133.95 | +7.7% | 67 | 0.53 |
|
BVT
|
22,450.00 | 76.3B | 3.19 | 1.94 | 1.99 | 11.4% | 14.0% | 60 | 34 | 20,286.87 | -6.9% | 62 | 1.11 |
|
WBC
|
3,012.00 | 12.6B | 3.39 | 4.12 | 2.62 | 16.8% | 16.8% | 52 | 29 | 2,185.34 | -19.8% | 63 | 0.78 |
|
DCP
|
2,742.00 | 23.5B | 6.00 | 4.16 | 3.23 | 11.5% | 16.2% | 42 | 24 | 1,395.53 | -36.8% | 60 | 1.18 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.